MeSH tree: D27.505.696.422.125
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
Jun 8, 2026
0
27
A new study led by researchers at the University of Texas at El Paso found that use of weight-loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use ...
Jun 8, 2026
0
5
GLP-1 receptor agonist drugs, used for the treatment of diabetes—and more recently, weight loss—are associated with a significantly lower long-term risk of knee replacement surgery as a result of osteoarthritis, finds an ...
Jun 2, 2026
0
5
Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn't return quickly, and ...
Jun 2, 2026
0
10
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, ...
Jun 2, 2026
0
10
A News and Perspectives report on emerging pharmaceutical access models in the United States has been published in the Journal of Medical Internet Research. In "Affordable GLP-1? When Digital Platforms Meet Policy Reform", ...
Jun 1, 2026
0
4
Many scientists are trying to determine just how much medical intervention can lengthen the human lifespan. But Daniel Promislow, senior scientist and scientific advisor at the Jean Mayer USDA Human Nutrition Research Center ...
Jun 1, 2026
0
4
Once confined to niche bodybuilding forums and hardcore gyms, unproven injectable peptides are now being openly marketed online to the average gym-goer by social media influencers—and regulators struggling to keep up.
May 31, 2026
0
12
As women navigate hot flashes, sleep issues and changing waistlines, there's another quieter change that can often occur during perimenopause and post-menopause that deserves just as much attention: heart health.
May 26, 2026
0
3
Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug in the European Union, the bloc's medicines regulator said on Friday.
May 22, 2026
0
8
